[VRDN] YoY Quarter Result on 30-Sep-2019 [#Q3]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- -26.24%
YoY- -24.63%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 1,195 208 0 695 944 1,631 889 5.05%
PBT -28,905 -14,043 -5,494 -11,230 -9,011 -5,834 -1,839 58.23%
Tax -880 91 -48 133 362 113 0 -
NP -28,025 -14,043 -5,494 -11,230 -9,011 -5,834 -1,839 57.42%
Tax Rate - - - - - - - -
Total Cost 29,220 14,251 5,494 11,925 9,955 7,465 2,728 48.44%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin -2,345.19 -6,751.44 0.00 -1,615.83 -954.56 -357.69 -206.86 49.85%
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
EPS -0.83 -1.26 -1.48 -5.42 -4.40 -4.06 -2.56 -17.10%
EPS Diluted -0.83 -1.26 -1.48 -5.42 -4.40 -4.06 -2.56 -17.10%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.